By: Richard L. Smith
An advanced robotic technology designed to help physicians detect lung cancer earlier is now available at Robert Wood Johnson University Hospital in partnership with Rutgers Cancer Institute, according to a statement released by the organizations.
Hospital officials announced the introduction of Ion robotic bronchoscopy, a minimally invasive system that allows interventional pulmonologists and thoracic surgeons to reach small, hard-to-access lung nodules and perform precise biopsies.
More than 70 percent of cancerous lung growths develop in the outer areas of the lungs, locations that have traditionally been difficult to biopsy.
Lung cancer remains the leading cause of cancer-related deaths in the United States.
The American Cancer Society estimates that more than 226,000 new cases and nearly 125,000 deaths will occur nationwide in 2025. In New Jersey alone, approximately 5,800 people are diagnosed each year.
Physicians say advanced tools such as robotic bronchoscopy, combined with artificial intelligence and imaging analysis, can improve early diagnosis, when treatment outcomes are more favorable.
“Early detection and diagnosis are critical for lung cancer patients,” said Dr. Neil Ninan, Director of Pulmonary Medicine for the Southern Region at RWJBarnabas Health.
He noted that the technology allows doctors to more easily access small nodules and obtain tissue samples, potentially leading to earlier treatment.
The Ion system uses robotic assistance and shape-sensing technology to navigate all segments of the lung with high accuracy. Its minimally invasive approach may reduce risk for certain patients compared to traditional biopsy methods.
The technology is also in use at several other RWJBarnabas Health hospitals across the state.
RWJUH and Rutgers Cancer Institute continue to promote early detection through their Lung Cancer Screening Program, which offers low-dose CT scans, care coordination, insurance support, smoking cessation services, and patient assistance such as translation and transportation.
Current screening guidelines recommend testing for individuals between ages 50 and 80 who have a significant smoking history and are either current smokers or have quit within the past 15 years.
Patients diagnosed with lung cancer have access to specialized care at the Jack & Sheryl Morris Cancer Center in New Brunswick, New Jersey’s only freestanding cancer hospital, where comprehensive treatment options and advanced therapies are available.